Committee for Orphan Medicinal Products (COMP): 8-10 October 2019
Date:
08/10/2019 to 10/10/2019
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Agenda - COMP agenda of the 8-10 October 2019 meeting (PDF/234.92 KB)
Draft
First published: 08/10/2019
EMA/COMP/548395/2019 -
List item
COMP meeting report on the review of applications for orphan designation: October 2019 (PDF/197.38 KB)
Adopted
First published: 15/10/2019
EMA/COMP/527035/2019